Mobile ECG Devices Global Market Opportunities and Strategies to 2035

This report describes and explains the mobile ECG devices market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global mobile ECG devices market reached a value of nearly $3.16 billion in 2025, having grown at a compound annual growth rate (CAGR) of 12.6% since 2020. The market is expected to grow from $3.16 billion in 2025 to $5.5 billion in 2030 at a rate of 11.7%. The market is then expected to grow at a CAGR of 10.4% from 2030 and reach $9.03 billion in 2035.

Growth in the historic period resulted from rising global prevalence of cardiovascular diseases (CVDs), increasing incidence of hypertension and related conditions, growing geriatric population and rising adoption of remote patient monitoring technologies. Factors that negatively affected growth in the historic period were regulatory and approval barriers and data privacy and cybersecurity concerns.

Going forward, expansion of telemedicine, rising health awareness and preventive care focus, growing investments in healthcare infrastructure and digital health systems and growth of home healthcare services will drive the growth. Factors that could hinder the growth of the mobile ECG devices market in the future include high cost of advanced devices and monitoring systems, dependence on smartphones and internet connectivity and impact of trade war and tariffs.

Market trends for the mobile ECG devices market include advancements in wearable telemetry systems for continuous remote cardiac monitoring, advancements in AI-enabled wearable health monitoring, advancements in continuous cardiac monitoring technology and advancing rapid cardiac assessment through point-of-care ECG technology.

The mobile ECG devices market is segmented by type into monitoring ECG systems and diagnostics ECG systems. The monitoring ECG systems market was the largest segment of the mobile ECG devices market segmented by type, accounting for 58.4% or $1.85 billion of the total in 2025. Going forward, the diagnostics ECG systems segment is expected to be the fastest growing segment in the mobile ECG devices market segmented by type, at a CAGR of 13.3% during 2025-2030.

The mobile ECG devices market is segmented by modality type into handheld, band, other modalities and pen. The handheld was the largest segment of the mobile ECG devices market segmented by modality type, accounting for 48.9% or $1.54 billion of the total in 2025. Going forward, the band segment is expected to be the fastest growing segment in the mobile ECG devices market segmented by modality type, at a CAGR of 15.7% during 2025-2030.

The mobile ECG devices market is segmented by end user hospitals, personal users, clinics and ambulatory services. The hospitals market was the largest segment of the mobile ECG devices market segmented by end user, accounting for 41% or $1.29 billion of the total in 2025. Going forward, the personal users segment is expected to be the fastest growing segment in the mobile ECG devices market segmented by end user, at a CAGR of 14.9% during 2025-2030.

North America was the largest region in the mobile ECG devices market, accounting for 33.4% or $1.05 billion of the total in 2025. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the mobile ECG devices market will be Asia-Pacific and Middle East where growth will be at CAGRs of 13.3% and 12.4% respectively. These will be followed by Africa and South America where the markets are expected to grow at CAGRs of 2.1% and 5% respectively.

The global mobile ECG devices market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 15.33% of the total market in 2024. iRhythm Technologies Inc. (Zio Patch) was the largest competitor with a 1.87% share of the market, followed by Mindray Medical International Limited with 1.79%, Nihon Kohden Corporation with 1.78%, GE Healthcare Technologies Inc with 1.76%, Medtronic plc with 1.66%, Philips Healthcare with 1.56%, Schiller AG with 1.53%, Edan Instruments with 1.43%, AliveCor (KardiaMobile) with 1.13% and BPL Medical Technologies Pvt. Ltd. with 0.80%.

The top opportunities in the mobile ECG devices market segmented by type will arise in the monitoring ECG systems segment, which will gain $1.2 billion of global annual sales by 2030. The top opportunities in the mobile ECG devices market segmented by modality will arise in the band segment, which will gain $1.0 billion of global annual sales by 2030. The top opportunities in the mobile ECG devices market segmented by end user will arise in the personal users segment, which will gain $844.6 million of global annual sales by 2030. The mobile ECG devices market size will gain the most in the USA at $631.8 million.

Player-adopted strategies in the mobile ECG devices market include focus on strengthening its market position by launching new products and enhancing its business operations through expanding partnerships.

Market-trend-based strategies for the mobile ECG devices market include focus on developing wearable telemetry systems to enable continuous real-time cardiac monitoring, improve early detection of heart rhythm abnormalities and support remote patient management outside traditional clinical settings, developing next-generation wearable health monitoring devices to enable continuous, real-time cardiac tracking, improve early detection of heart rhythm abnormalities and support proactive, remote patient care, advancing ambulatory cardiac monitoring to enable continuous, real-time heart rhythm tracking, improve early detection of arrhythmias and support proactive, remote patient management outside traditional clinical settings and developing point-of-care ECG technology to enable rapid, on-site cardiac assessment, improve early detection of heart rhythm abnormalities and support timely clinical decision-making in both clinical and remote care settings.

To take advantage of the opportunities, the analyst recommends the mobile ECG devices companies to focus on wearable telemetry systems for continuous cardiac monitoring, focus on next-generation wearable devices with AI-enabled cardiac insights, focus on ambulatory cardiac monitoring with AI-driven detection, focus on point-of-care ECG technology for rapid cardiac assessment, focus on diagnostic ECG systems for accelerated expansion, focus on wearable ECG band segment for high growth, expand in emerging markets, continue to focus on developed markets, focus on expanding multi-channel distribution with healthcare integration, focus on value based tiered pricing for mobile ECG devices, focus on building clinical credibility and trust, focus on driving targeted engagement and conversion and focus on personal users segment for accelerated growth.

This product will be delivered within 3-5 business days.